152 related articles for article (PubMed ID: 8079664)
21. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
[TBL] [Abstract][Full Text] [Related]
22. Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue.
Delaisse JM; Eeckhout Y; Vaes G
Endocrinology; 1988 Jul; 123(1):264-76. PubMed ID: 2838255
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen activators are involved in the degradation of bone by osteoclasts.
Everts V; Daci E; Tigchelaar-Gutter W; Hoeben KA; Torrekens S; Carmeliet G; Beertsen W
Bone; 2008 Nov; 43(5):915-20. PubMed ID: 18691680
[TBL] [Abstract][Full Text] [Related]
24. Effects of experimental conditions on the release of 45calcium from prelabeled fetal mouse long bones.
van Beek E; Oostendorp-van de Ruit M; van der Wee-Pals L; Bloys H; van de Bent C; Papapoulos S; Löwik C
Bone; 1995 Jul; 17(1):63-9. PubMed ID: 7577160
[TBL] [Abstract][Full Text] [Related]
25. The plasminogen activator inhibitor system in bone cell function.
Allan EH; Martin TJ
Clin Orthop Relat Res; 1995 Apr; (313):54-63. PubMed ID: 7641498
[TBL] [Abstract][Full Text] [Related]
26. Direct stimulation of bone resorption by thyroid hormones.
Mundy GR; Shapiro JL; Bandelin JG; Canalis EM; Raisz LG
J Clin Invest; 1976 Sep; 58(3):529-34. PubMed ID: 182721
[TBL] [Abstract][Full Text] [Related]
27. Human breast-cancer cells stimulate the fusion, migration and resorptive activity of osteoclasts in bone explants.
Tumber A; Morgan HM; Meikle MC; Hill PA
Int J Cancer; 2001 Mar; 91(5):665-72. PubMed ID: 11267975
[TBL] [Abstract][Full Text] [Related]
28. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
Lerner UH; Ransjö M; Ljunggren O; Klaushofer K; Hoffmann O; Peterlik M
J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
[TBL] [Abstract][Full Text] [Related]
29. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells.
Yamashita T; Asano K; Takahashi N; Akatsu T; Udagawa N; Sasaki T; Martin TJ; Suda T
J Cell Physiol; 1990 Dec; 145(3):587-95. PubMed ID: 1703173
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
Väänänen K
Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
[TBL] [Abstract][Full Text] [Related]
31. Cystatin C, and inhibitor of bone resorption produced by osteoblasts.
Lerner UH; Johansson L; Ranjsö M; Rosenquist JB; Reinholt FP; Grubb A
Acta Physiol Scand; 1997 Sep; 161(1):81-92. PubMed ID: 9381954
[TBL] [Abstract][Full Text] [Related]
32. Effects of calcitonin gene-related peptide on bone resorption mediated by interleukin-1.
Zhang WZ; Yu SF; Zheng LF
Chin Med J (Engl); 1994 May; 107(5):351-4. PubMed ID: 7924575
[TBL] [Abstract][Full Text] [Related]
33. Human parathyroid hormone-related peptide-(107-111) does not inhibit bone resorption in neonatal mouse calvariae.
Sone T; Kohno H; Kikuchi H; Ikeda T; Kasai R; Kikuchi Y; Takeuchi R; Konishi J; Shigeno C
Endocrinology; 1992 Dec; 131(6):2742-6. PubMed ID: 1306984
[TBL] [Abstract][Full Text] [Related]
34. Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants.
van der Pluijm G; Löwik CW; de Groot H; Alblas MJ; van der Wee-Pals LJ; Bijvoet OL; Papapoulos SE
J Bone Miner Res; 1991 Nov; 6(11):1203-10. PubMed ID: 1839590
[TBL] [Abstract][Full Text] [Related]
35. Calcitonin receptor expression and its regulation by 1 alpha-25-dihydroxyvitamin D3 during de novo osteoclast formation in organ cultures of fetal mouse metatarsals.
Minkin C; Yu XH
Bone Miner; 1991 Jun; 13(3):191-200. PubMed ID: 1650619
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoids stimulate resorption in fetal rat parietal bones in vitro.
Gronowicz G; McCarthy MB; Raisz LG
J Bone Miner Res; 1990 Dec; 5(12):1223-30. PubMed ID: 2127506
[TBL] [Abstract][Full Text] [Related]
37. Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix.
van der Pluijm G; Most W; van der Wee-Pals L; de Groot H; Papapoulos S; Löwik C
Endocrinology; 1991 Sep; 129(3):1596-604. PubMed ID: 1874190
[TBL] [Abstract][Full Text] [Related]
38. DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.
Lorenzo JA; Raisz LG; Hock JM
J Clin Invest; 1983 Dec; 72(6):1924-9. PubMed ID: 6643680
[TBL] [Abstract][Full Text] [Related]
39. The effects of 1,25-dihydroxyvitamin D3 on osteoclast formation in fetal mouse metatarsal organ cultures.
Tao H; Minkin C
Bone; 1994; 15(2):217-23. PubMed ID: 8086241
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of glucocorticoids on bone resorption in neonatal mouse calvariae stimulated by peptide and steroid-like hormones.
Conaway HH; Grigorie D; Lerner UH
J Endocrinol; 1997 Dec; 155(3):513-21. PubMed ID: 9487996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
